A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.
Joshua F ZeidnerTara L LinCarlos E VigilGil FineM Yair LevyAziz NazhaAleksandra HolowieckaDaniel J LeeKaren YeeAndrew DalovisioEunice S WangJuan M Bergua BurguesJeffrey SchriberMark R LitzowOlga FrankfurtTeresa Bernal Del CastilloVijaya Raj BhattBhavana BhatnagarPriyanka MehtaRichard DillonMaria Vidriales VicenteStephen AnthonyDavid BearssPau MontesinosB Douglas SmithPublished in: Blood cancer journal (2021)